Tick-borne Relapsing Fever is a bacterial infection transferred through Ornithodoros tick bites. The Ornithodoros ticks are found in Africa, Spain, Asia, and the western United States. The main symptom of tick-borne relapsing fever is a recurring fever that may last several days and then disappear for up to a week before reappearing. Without treatment, the disease will usually resolve itself after 1-4 episodes of fever. With proper diagnosis and treatment, Tick-borne relapsing fever can be cured after approximately 10-14 days. There is no vaccine for tick-borne relapsing fever, but the disease can be prevented by minimizing exposure to ticks, especially when in rodent-infested buildings, and by wearing protective clothing and using tick repellents.
Tick-born Relapsing Fever Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Tick-born Relapsing Fever below!
For more information on how to use Laverne, please read the How to Guide.
We have 1038 products for the study of Tick-born Relapsing Fever that can be applied to Chromatin Immunoprecipitation, Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
Tick-born Relapsing Fever is also known as Tick-borne Relapsing Fever.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.